{"id":"cholates","rwe":[],"tags":[],"phase":"discontinued","safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[],"contraindications":[],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"status":"discontinued","trials":["NCT01907074","NCT07473817","NCT03087968","NCT03726229","NCT01579162","NCT02506335","NCT03294850","NCT03294941","NCT07009132","NCT06899152","NCT02400216","NCT02523196","NCT03583996","NCT01644539"],"aliases":[],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"aiSummary":"","brandName":"Cholates","companyId":"baylor-research-institute","ecosystem":[],"mechanism":{"target":"","novelty":"","modality":"Small molecule","drugClass":"","explanation":"","oneSentence":"","technicalDetail":""},"commercial":null,"references":[],"biosimilars":[],"companyName":"Baylor Research Institute","competitors":[],"dataSources":[{"url":"https://clinicaltrials.gov","name":"ClinicalTrials.gov","fields":["trialDetails","trials"],"retrievedDate":"2026-04-07"}],"genericName":"Cholates","indications":{"approved":[],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT01907074","phase":"Phase 2","title":"Quantitative Liver Function Tests Using Cholates","status":"TERMINATED","sponsor":"Baylor Research Institute","isPivotal":false,"enrollment":103,"indication":"End Stage Liver Disease","completionDate":"2025-05-20"},{"nctId":"NCT07473817","phase":"N/A","title":"Validation of Different Methods for HepQuant DuO® Blood Sample Collection","status":"NOT_YET_RECRUITING","sponsor":"HepQuant, LLC","isPivotal":false,"enrollment":200,"indication":"Healthy Adult Participants, Liver Disease Chronic","completionDate":"2027-04-20"},{"nctId":"NCT03087968","phase":"EARLY/Phase 1","title":"Evaluation of HepQuant SHUNT to Assess Liver Disease; Substudy Within GS-US-416-2124","status":"WITHDRAWN","sponsor":"HepQuant, LLC","isPivotal":false,"enrollment":0,"indication":"Severe Alcoholic Hepatitis","completionDate":"2017-09-13"},{"nctId":"NCT03726229","phase":"N/A","title":"Development of a Reliable Means for Functional Assessment of Liver Performance After the Fontan Operation: Dual Cholate Clearance Assay","status":"COMPLETED","sponsor":"University of Pennsylvania","isPivotal":false,"enrollment":50,"indication":"Fontan Procedure","completionDate":"2022-05-25"},{"nctId":"NCT01579162","phase":"NA","title":"Intra-Individual Reproducibility of the Non-Invasive Assessment of the Portal Circulation","status":"COMPLETED","sponsor":"HepQuant, LLC","isPivotal":false,"enrollment":48,"indication":"Hepatitis C, Chronic, Non-Alcoholic Fatty Liver Disease","completionDate":"2015-04"},{"nctId":"NCT02506335","phase":"EARLY/Phase 1","title":"Liver Function Measured by HepQuant-SHUNT in the Prediction of Outcomes in Patients With Passive Hepatic Congestion Secondary to Congenital Heart Disease (CHD) or Cardiomyopathy","status":"COMPLETED","sponsor":"Northwestern University","isPivotal":false,"enrollment":14,"indication":"Liver Disease, Cardiovascular Disease","completionDate":"2018-05-01"},{"nctId":"NCT03294850","phase":"NA","title":"Evaluation of Biomarkers to Quantify Liver Pathology in Patients With Presumed Non-Alcoholic Steatohepatitis at Baseline and Following Bariatric Surgery (BARI)","status":"COMPLETED","sponsor":"AdventHealth Translational Research Institute","isPivotal":false,"enrollment":14,"indication":"NASH - Nonalcoholic Steatohepatitis; NAFLD - Nonalcoholic Fatty Liver Disease","completionDate":"2020-09-11"},{"nctId":"NCT03294941","phase":"Phase 2","title":"The HepQuant SHUNT Test for Monitoring Liver Disease and Treatment Effects by Measuring Liver Function and Physiology","status":"TERMINATED","sponsor":"HepQuant, LLC","isPivotal":false,"enrollment":17,"indication":"NASH - Nonalcoholic Steatohepatitis","completionDate":"2019-09-11"},{"nctId":"NCT07009132","phase":"N/A","title":"Hepatic Perfusion and Liver Health as Assessed by Dual Cholate Clearance Assay in Fontan-associated Liver Disease (FALD)","status":"RECRUITING","sponsor":"HepQuant, LLC","isPivotal":false,"enrollment":75,"indication":"Fontan, Right Heart Failure","completionDate":"2031-12"},{"nctId":"NCT06899152","phase":"NA","title":"HepQuant: Pilot Study to Assess the Role of Blood-based Biomarkers and Quantitative MR Imaging for Patients Receiving Radiation Therapy for Liver Cancer","status":"RECRUITING","sponsor":"Montefiore Medical Center","isPivotal":false,"enrollment":40,"indication":"Liver Cancer, Hepatocellular Carcinoma","completionDate":"2031-07"},{"nctId":"NCT02400216","phase":"N/A","title":"A Multidisciplinary Approach to Deciphering the Mechanisms Involved In Microbial Translocation Across the Spectrum of HCV Associated Liver Fibrosis","status":"COMPLETED","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","isPivotal":false,"enrollment":30,"indication":"Cirrhosis","completionDate":"2017-04-25"},{"nctId":"NCT02523196","phase":"Phase 3","title":"Correlation and Comparison of the HepQuant® Disease Severity Index (DSI) With Hepatic Venous Pressure Gradient (HVPG)","status":"COMPLETED","sponsor":"University of Colorado, Denver","isPivotal":true,"enrollment":20,"indication":"Liver Disease","completionDate":"2017-02-23"},{"nctId":"NCT03583996","phase":"NA","title":"The HepQuant SHUNT Liver Diagnostic Kit for Likelihood of Large Esophageal Varices: The SHUNT-V Study","status":"COMPLETED","sponsor":"HepQuant, LLC","isPivotal":false,"enrollment":306,"indication":"Chronic Liver Disease","completionDate":"2022-10-22"},{"nctId":"NCT01644539","phase":"NA","title":"Functional MRI of Satiety, the Interaction Between Gastric and Oral Stimulation and Related Hormones in Healthy Men","status":"COMPLETED","sponsor":"UMC Utrecht","isPivotal":false,"enrollment":16,"indication":"Appetite Regulation","completionDate":"2011-12"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"icon":"","route":"","frequency":"","formulation":""},"formularyStatus":[],"apiManufacturers":[],"developmentCodes":[],"ownershipHistory":[],"therapeuticAreas":["Other"],"biosimilarFilings":[],"firstApprovalDate":"","companionDiagnostics":[],"firstApprovalCountry":null,"genericManufacturerList":[],"modality":"Small molecule","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}